Community Mental Health Services: Clinical Trials

9 trials of Community Mental Health Services, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Unknown 1
Phase 21Recruiting 1
Phase 41Completed 1

Follow Community Mental Health Services: new trials by email Literature Review of Community Mental Health Services trials Research Report on Community Mental Health Services

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Hepatic Artery Infusion Pump (HAIP), Standard Treatment, Community Treatment - Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma
Phase 2RecruitingMichael J Cavnar, MD802026-01-232026-02-04
Assertive Community Treatment for Alcohol Misuse Disorder Patients Who Are High Utilizers of Emergency Department Services
Assertive Community Treatment (ACT) - Alcoholism and Alcohol Abuse, Alcohol Use Disorder
Not yet recruitingKhoo Teck Puat Hospital3002020-08-012020-08-05
Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)
Cognitive Adaptation Training, Community Treatment - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedThe University of Texas Health Science Center at San Antonio2052019-04-042024-08-09
Assertive Community Treatment for Patients Suffering From Substance Use Disorders
Assertive Community Treatment - Substance Use Disorders
CompletedUniversity Hospital, Geneva292017-12-012025-05-21
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients
Assertive community treatment, Basic public health services. - Schizophrenia
Not applicableCompletedShanghai Mental Health Center1982017-07-012020-08-13
Assertive Community Treatment With CBT and SST for Schizophrenia
Cognitive Behavioral Social Skills Training (CBSST), Assertive Community Treatment (ACT) - Schizophrenia
Not applicableCompletedVeterans Medical Research Foundation1782012-02-012016-11-17
Integration of Illness Management and Recovery Within ACT
Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR) - Severe Mental Illness, Schizophrenia
Not applicableCompletedUniversity of Washington1012011-06-072017-03-09
Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders
Assertive Community Treatment (ACT) - Schizophrenia
Phase 4CompletedUniversitätsklinikum Hamburg-Eppendorf1202005-04-012010-03-05
Assertive Community Treatment in Copenhagen
Assertive Community Treatment, Treatment in Community Mental Health Center - Schizophrenia, Bipolar Disorder
Not applicableUnknownBispebjerg Hospital4002004-01-012005-09-26

Conditions studied

Schizophrenia (6)  ·  Bipolar Disorder (2)  ·  Psychotic Disorders (2)  ·  Alcoholism (1)  ·  Cholangiocarcinoma (1)  ·  Emergencies (1)  ·  Mental Disorders (1)  ·  Substance-Related Disorders (1)

Sponsors

Bispebjerg Hospital (1)  ·  Khoo Teck Puat Hospital (1)  ·  Michael J Cavnar, MD (1)  ·  Shanghai Mental Health Center (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  University Hospital, Geneva (1)  ·  University of Washington (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)  ·  Veterans Medical Research Foundation (1)

Countries

United States (3)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Switzerland (1)

Top investigators

Dawn Velligan, PhD (1)  ·  Eric Granholm, PhD (1)  ·  Gary Morse, PhD (1)  ·  Jun Cai (1)  ·  Louise Penzenstadler, MD (1)  ·  Maria Monroe-DeVita, PhD (1)  ·  Martin Lambert, MD (1)  ·  Merete Nordentoft, Ph.D (1)  ·  Michael Cavnar, MD (1)

Results publications

PMID 10891633, PMID 20361911, PMID 22490266, PMID 23502815, PMID 26284824, PMID 26424639, PMID 30406858, PMID 31814102, PMID 38419049, PMID 41391103, PMID 41391109

NIH funding

R01MH091057 (1), R01MH117101 (1)